The Usefulness of Impedance Cardiography for Predicting Beneficial Effects of Cardiac Rehabilitation in Patients with Heart Failure

Table 1

Baseline characteristics.

	Study group (𝑛=50)
Men, 𝑛 (%)	44 (88.0)
Age (years)	56.2 ± 8.8
LVEF (%)	30.0 ± 7.5
NYHA class II, 𝑛 (%)	30 (60.0)
NYHA class III, 𝑛 (%)	20 (40.0)
BMI (kg × m^−2)	28.7 ± 3.8
HF aetiology, 𝑛 (%)
Ischaemic	42 (84.0)
Nonischaemic	8 (16.0)
Past medical history, 𝑛 (%)
Myocardial infarction	38 (76.0)
Diabetes	14 (28.0)
Dyslipidaemia	39 (78.0)
Hypertension	26 (52.0)
Medications, 𝑛 (%)
ACE inhibitor	46 (92.0)
Angiotensin receptor blocker	6 (12.0)
Beta-blocker	50 (100.0)
Loop diuretic	40 (80.0)
Spironolactone	47 (94.0)
Aspirin	43 (86.0)
Statin	46 (92.0)

ACE: angiotensin-converting enzyme, BMI: body mass index, CABG: coronary artery bypass grafting; HF: heart failure; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association.